Ignite Creation Date:
2025-12-24 @ 3:23 PM
Ignite Modification Date:
2026-05-02 @ 11:35 PM
Study NCT ID:
NCT04738292
Status:
TERMINATED
Last Update Posted:
2024-05-03
First Post:
2021-02-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Sponsor:
University of Wisconsin, Madison
Organization: